We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
With less than two months to go before election day, drug prices are increasingly being used in politics, with both the Democratic party and AARP releasing new reports.
The FDA is splitting up responsibilities for reviewing direct-to-consumer (DTC) ads based on the product type in order to better address a growing workload that is proving overwhelming for its staff, a high-ranking agency official says.
Patients who take low-dose aspirin to help prevent heart attacks may interfere with that protection if they also take the painkiller ibuprofen, according to an FDA announcement.
An FDA employee who has publicly criticized the agency for not doing more to protect the public against the cardiovascular health risks associated with Vioxx is calling for patients to take naproxen instead of Cox-2 drugs and is urging the agency to reject Merck’s Vioxx successor Arcoxia, in an editorial recently published in the Journal of the American Medical Association.
Barr Pharmaceuticals, faced with generic competition to its birth-control drug Seasonale after an unsuccessful attempt for a patent reissue, launched an authorized generic Sept. 7 — the day Watson Pharmaceuticals received final FDA approval to market its version.
Seniors could enjoy several more weeks or even months of drug cost coverage under Medicare by using generic instead of brand drugs, according to a new report by the Pharmaceutical Benefit Care Association (PCMA).
For patients who have recently suffered a heart attack, Pfizer’s Lipitor may reduce the risk of a recurrence by 46 percent compared with Zocor, according to trial results released Sept. 6 by Pfizer.
Health Canada’ Health Products and Food Branch (HPFB) granted marketing approval to 210 medicines in 2005, including 24 never before available in the country, according to the agency’s 2005 Annual Summary of Performance.
The FDA is requesting that Genentech provide an update of the company’s clinical data for the use of Avastin to treat breast cancer, the company announced Sept. 11.
Human-implantable radio frequency identification (RFID) chip manufacturer VeriChip recently made the first sale of its radio frequency (RF) infant protection system in Canada and is in talks with the U.S. military about another under-the-skin chip.